TITLE:
Evaluation of Anti-Hyperglycemic and Anti-Hyperlipidemic Activities of Water Kefir as Probiotic on Streptozotocin-Induced Diabetic Wistar Rats
AUTHORS:
Muneer Alsayadi, Yaser Al Jawfi, Meriem Belarbi, Zoubida Soualem-Mami, Hafida Merzouk, Daoudi Chaban Sari, Fatima Sabri, Meriem Ghalim
KEYWORDS:
Component, Formatting, Style, Styling, Anti-Hyperglycemic, Anti-Hyperlipidaemic, Water Kefir, Diabetes, Wistar Rat
JOURNAL NAME:
Journal of Diabetes Mellitus,
Vol.4 No.2,
April
21,
2014
ABSTRACT:
Diabetes mellitus is a predominant chronic disease which causes mortality
of millions of people yearly. Its prevalence is on the rise worldwide. Water
kefir is fermented food produced by a matrix of polysaccharides containing
bacteria and yeasts, with therapeutic properties. Our study aimed to evaluate
anti-hyperglycemic and anti-hyperlipidemic activities of water kefir on
streptozotocin-induced diabetic Wistar rats. Adult Wistar rats were made
diabetic by intraperitoneal injection of streptozotocin, and were given or not
kefir in drinking water for 5 weeks. Body weight, glucose and lipid levels were
measured. The results demonstrated evident improvement in body weight, glucose,
and lipid profiles of treated rats comparing with diabetic or control rats. Water
kefir is found to be less cost hypoglycemic and hypolipidimic treatment and
less time consuming. Water kefir can potentially be useful food for diabetes to
control glucose and lipid levels.